Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Corneal nerve fiber loss as a marker of neuropathy in patients with Macular telangiectasia type 2

Simone Tzaridis; Katie Nardo; Ioannis N. Petropoulos; Roberto Bonelli; Jennifer Trombley; Lea Scheppke; Barbara Hart; Scott Hau; Abraham Olvera-Barrios; Yanling Ouyang; Catherine A Egan; Ferenc B. Sallo; Paul S Bernstein; Rayaz A. Malik; Marin Gantner; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6045.

ARVO Annual Meeting Abstract June 2023

Detection of photoreceptor layer thinning prior to the presence of an EZ break in MacTel Type 2

Ferenc B Sallo; Mustafa Arikan; Watjana Lilaonitkul; Adam M Dubis; Valérie Krivosic; Alain Gaudric; Emily Y. Chew; Alan C Bird; Daniel Pauleikhoff

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3681.

ARVO Annual Meeting Abstract June 2020

SD-OCT baseline characteristics of diabetic macular oedema can predict differential time to recurrence and morphological features in eyes treated with dexamethasone intravitreal implants.

Ferenc B Sallo; Chiara M Eandi; Daniele De Geronimo; Daniela Giannini; Maria Sole Polito; Yannick Le Mer; Monica Varano; Mariacristina Parravano

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4871.

ARVO Annual Meeting Abstract July 2019

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Emily Y Chew; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Ferenc B Sallo; Tjebo Heeren; Catherine A Egan; Peter Charbel Issa; Konstatinos Balaskas; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1335.

ARVO Annual Meeting Abstract July 2019

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Ferenc B Sallo; Vincent Rocco; Irene Leung; Adam M Dubis; Ute EK Wolf-Schnurrbusch; Catherine A Egan; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5049.

ARVO Annual Meeting Abstract July 2018

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Adam M Dubis; Irene Leung; Traci E Clemons; Daniel Pauleikhoff; Emily Y. Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3139.

ARVO Annual Meeting Abstract June 2017

Distribution and progression patterns of retinal low-reflective intraretinal spaces in Type 2 Idiopathic Macular Telangiectasia.

Ferenc B Sallo; Irene Leung; Ute EK Wolf-Schnurrbusch; Bingqian Liu; Kiyoko Gocho; Valerie Krivosic; Tunde Peto; Adam M Dubis; Daniel Pauleikhoff; Traci E Clemons; Michel Paques; Emily Chew; Alain Gaudric; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3687.

ARVO Annual Meeting Abstract September 2016

Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: 48 Month Results from the Phase 1 Safety Trial

Traci E Clemons; Emily Y Chew; Tunde Peto; Ferenc B Sallo; Irene Leung

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2038.

ARVO Annual Meeting Abstract September 2016

Functional and structural measures of disease severity from a Phase 1 clinical trial in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Irene Leung; Simona Esposti; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4955.

ARVO Annual Meeting Abstract June 2015

Three-dimensional characteristics of outer retinal atrophy in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Irene Leung; Vincent Rocco; Meike Zeimer; Britta Heimes; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto; MacTel Study Group.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2783.

ARVO Annual Meeting Abstract April 2014

Progression of Inner Segment/Outer Segment junction breaks in Macular Telangectasia type 2 and association with change in visual acuity over a period of 5 years

Konstantinos Balaskas; Ferenc B Sallo; Irene leung; Traci E Clemons; Emily Y Chew; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4573.

ARVO Annual Meeting Abstract April 2014

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Stela Vujosevic; Ferenc B Sallo; Irene leung; Daniela Ioana Florea; Daniel Pauleikhoff; Traci E Clemons; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5013.

ARVO Annual Meeting Abstract April 2014

Patterns of retinal sensitivity loss in type 2 idiopathic macular telangiectasia (MacTel).

Ferenc B Sallo; Irene Leung; Stela Vujosevic; Traci E Clemons; Alan C Bird; Daniel Pauleikhoff; Tunde Peto; MacTel Study group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5948.

ARVO Annual Meeting Abstract April 2014

Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).

Irene Leung; Ferenc B Sallo; Daniel Pauleikhoff; Alan C Bird; Traci E Clemons; Tunde Peto; MacTel Study group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5950.

ARVO Annual Meeting Abstract April 2014

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

Tunde Peto; Stela Vujosevic; Ferenc B Sallo; Daniela Florea; Irene Leung; Traci E Clemons; Emily Y Chew; Alan C Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):674.

Retina November 2012

The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia

PDF

Ferenc B. Sallo; Tunde Peto; Catherine Egan; Ute E. K. Wolf-Schnurrbusch; Traci E. Clemons; Mark C. Gillies; Daniel Pauleikhoff; Gary S. Rubin; Emily Y. Chew; Alan C. Bird; the MacTel Study Group
TAGS: diagnostic imaging, eye, face, natural history, telangiectasis, retina
Invest. Ophthalmol. Vis. Sci.. 2012; 53(12):7889-7895. https://doi.org/10.1167/iovs.12-10765

Retina September 2012

“En face” OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia

PDF

Ferenc B. Sallo; Tunde Peto; Catherine Egan; Ute E. K. Wolf-Schnurrbusch; Traci E. Clemons; Mark C. Gillies; Daniel Pauleikhoff; Gary S. Rubin; Emily Y. Chew; Alan C. Bird; the MacTel Study Group10
TAGS: diagnostic imaging, eye, face, telangiectasis
Invest. Ophthalmol. Vis. Sci.. 2012; 53(10):6145-6152. https://doi.org/10.1167/iovs.12-10580

ARVO Annual Meeting Abstract March 2012

Correlation of microperimetry results with 'en face' imaging of the IS/OS junction layer in Type 2 Macular Telangiectasia

Ferenc B. Sallo; Stela Vujosevic; Ute E. Wolf-Schnurrbusch; Daniel Pauleikhoff; Alan C. Bird; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5200.

ARVO Annual Meeting Abstract April 2011

Function And Phenotype In The Natural History Of Type 2 Idiopathic Macular Telangiectasia

Ferenc B. Sallo; Tunde Peto; Emily Y. Chew; Alan C. Bird; Traci E. Clemons; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4523.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Corneal nerve fiber loss as a marker of neuropathy in patients with Macular telangiectasia type 2

Detection of photoreceptor layer thinning prior to the presence of an EZ break in MacTel Type 2

SD-OCT baseline characteristics of diabetic macular oedema can predict differential time to recurrence and morphological features in eyes treated with dexamethasone intravitreal implants.

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Distribution and progression patterns of retinal low-reflective intraretinal spaces in Type 2 Idiopathic Macular Telangiectasia.

Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: 48 Month Results from the Phase 1 Safety Trial

Functional and structural measures of disease severity from a Phase 1 clinical trial in type 2 idiopathic macular telangiectasia.

Three-dimensional characteristics of outer retinal atrophy in type 2 idiopathic macular telangiectasia.

Progression of Inner Segment/Outer Segment junction breaks in Macular Telangectasia type 2 and association with change in visual acuity over a period of 5 years

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Patterns of retinal sensitivity loss in type 2 idiopathic macular telangiectasia (MacTel).

Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia

“En face” OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia

Correlation of microperimetry results with 'en face' imaging of the IS/OS junction layer in Type 2 Macular Telangiectasia

Function And Phenotype In The Natural History Of Type 2 Idiopathic Macular Telangiectasia

To View More...

You must be signed into an individual account to use this feature.